23.41
2.27%
0.52
After Hours:
23.41
Surgery Partners Inc stock is traded at $23.41, with a volume of 1.55M.
It is up +2.27% in the last 24 hours and down -20.56% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
See More
Previous Close:
$22.89
Open:
$23.04
24h Volume:
1.55M
Relative Volume:
1.77
Market Cap:
$2.91B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-41.80
EPS:
-0.56
Net Cash Flow:
$204.10M
1W Performance:
+4.00%
1M Performance:
-20.56%
6M Performance:
-7.80%
1Y Performance:
-27.46%
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
23.41 | 2.91B | 2.89B | -33.80M | 204.10M | -0.56 |
HCA
Hca Healthcare Inc
|
325.47 | 83.32B | 69.62B | 5.93B | 5.88B | 20.33 |
THC
Tenet Healthcare Corp
|
141.98 | 13.97B | 20.97B | 3.13B | 2.39B | 4.33 |
DVA
Davita Inc
|
165.63 | 13.81B | 12.67B | 827.68M | 1.42B | 5.03 |
UHS
Universal Health Services Inc
|
203.50 | 13.34B | 15.42B | 1.03B | 956.84M | 9.53 |
FMS
Fresenius Medical Care Ag Adr
|
22.48 | 13.16B | 20.87B | 715.14M | 1.67B | 0.8156 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-14-24 | Initiated | UBS | Buy |
Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jun-28-24 | Initiated | Macquarie | Outperform |
Mar-06-24 | Initiated | Barclays | Equal Weight |
Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
May-12-23 | Initiated | Mizuho | Buy |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-10-22 | Resumed | Citigroup | Buy |
Nov-30-21 | Initiated | Barclays | Overweight |
Nov-29-21 | Upgrade | Stifel | Hold → Buy |
Nov-01-21 | Initiated | JP Morgan | Neutral |
Oct-18-21 | Initiated | SVB Leerink | Outperform |
Sep-10-21 | Initiated | Cowen | Market Perform |
Jun-23-21 | Resumed | Stifel | Hold |
Sep-17-20 | Reiterated | The Benchmark Company | Buy |
Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
Jan-14-20 | Reiterated | The Benchmark Company | Buy |
Nov-16-18 | Initiated | UBS | Neutral |
Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
Jun-28-18 | Upgrade | Stifel | Sell → Hold |
Jan-30-18 | Reiterated | The Benchmark Company | Buy |
Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
Aug-09-17 | Downgrade | Stifel | Hold → Sell |
Apr-24-17 | Reiterated | Stifel | Hold |
Mar-10-17 | Downgrade | Stifel | Buy → Hold |
Jan-31-17 | Initiated | The Benchmark Company | Buy |
Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
Oct-27-15 | Initiated | Stifel | Buy |
Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
(SGRY) Long Term Investment Analysis - Stock Traders Daily
Surgery Partners' SWOT analysis: outpatient shift drives stock outlook - Investing.com
Principal Financial Group Inc. Invests $1.47 Million in Surgery Partners, Inc. (NASDAQ:SGRY) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Takes Position in Surgery Partners, Inc. (NASDAQ:SGRY) - MarketBeat
Key Takeaways From Surgery Partners Analyst Ratings - Benzinga
Surgery Partners Inc (SGRY) Shares Up 4.19% on Nov 19 - GuruFocus.com
Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Surgery Partners stock hits 52-week low at $22.19 - Investing.com
Surgery Partners stock hits 52-week low at $22.19 By Investing.com - Investing.com UK
State of New Jersey Common Pension Fund D Invests $1.97 Million in Surgery Partners, Inc. (NASDAQ:SGRY) - MarketBeat
BelHealth-backed NavaDerm Partners sells Dermatology and Surgery Associates - PE Hub
Royce & Associates LP Purchases 55,545 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) - MarketBeat
Victory Capital Management Inc. Boosts Stake in Surgery Partners, Inc. (NASDAQ:SGRY) - MarketBeat
USOSM Expands in Northeast United States - The Manila Times
Sivik Global Healthcare LLC Lowers Stake in Surgery Partners, Inc. (NASDAQ:SGRY) - MarketBeat
TD Cowen cuts Surgery Partners stock target, retains Buy on outcomes - Investing.com UK
Surgery Partners Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Jefferies cuts Surgery Partners target to $40, maintains Buy rating By Investing.com - Investing.com Canada
Relative Strength Alert For Surgery Partners - Nasdaq
USOSM Partners With Leading OMS Practice in Brockton, Massachusetts - Dentistry Today
Barclays cuts Surgery Partners shares target, equalweight rating on challenges - Investing.com Canada
Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2024 Earnings Call Transcript - Insider Monkey
Duly Health sells portion of Lombard, Westmont surgery centers - Crain's Chicago Business
Surgery Partners Inc (SGRY) Q3 2024 Earnings Call Highlights: Ro - GuruFocus.com
Surgery Partners Inc (SGRY) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance
Surgery Partners Reports Q3 Revenue Growth Amid Challenges - TipRanks
Surgery Partners: Q3 Earnings Snapshot - CT Insider
Earnings call: Surgery Partners reported a net revenue of $770 million - Investing.com Australia
Surgery Partners Inc earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Surgery Partners Inc (SGRY) Shares Down 9.02% on Nov 12 - GuruFocus.com
Surgery Partners Inc (SGRY) Q3 2024 Earnings: Revenue Hits $770. - GuruFocus.com
Surgery Partners, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Surgery Partners shares drop 10.5% after Q3 earnings miss By Investing.com - Investing.com South Africa
Surgery Partners shares drop 10.5% after Q3 earnings miss - Investing.com Canada
Surgery Partners (SGRY) Misses Q3 Earnings Estimates - Yahoo Finance
Surgery Partners, Inc. Announces Third Quarter 2024 Results - The Manila Times
Surgery Partners Q3 Revenue Surges 14.3% to $770.4M, EBITDA Jumps 22% Despite Net Loss | SGRY Stock News - StockTitan
Earnings To Watch: Surgery Partners Inc (SGRY) Reports Q3 2024 R - GuruFocus.com
Earnings To Watch: Surgery Partners Inc (SGRY) Reports Q3 2024 Result - Yahoo Finance
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt - Simply Wall St
Wellington Management Group LLP Adjusts Stake in Surgery Partners Inc - GuruFocus.com
Surgery Partners Inc (SGRY) Stock Price Up 3.21% on Nov 7 - GuruFocus.com
United Surgical Partners Settles 401(k) Mismanagement Suit - Law360
Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Surgery Partners (SGRY) Scheduled to Post Earnings on Tuesday - MarketBeat
Surgery Partners' (SGRY) "Outperform" Rating Reiterated at Macquarie - MarketBeat
Decoding 9 Analyst Evaluations For Surgery Partners - Benzinga
Surgery Partners Inc (SGRY) Shares Up 2.96% on Nov 4 - GuruFocus.com
(SGRY) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Surgery Partners Inc (SGRY) Shares Down 3.82% on Oct 25 - GuruFocus.com
Surgery Partners (NASDAQ:SGRY) Shares Gap DownWhat's Next? - MarketBeat
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):